In Vitro Study of Neuroprotective Properties of GK-2, a New Original Nerve Growth Factor Mimetic

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Bulletin of experimental biology and medicine

• Publication date

  2011-03-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10517-011-1202-6PMID 22235396
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Target Identification for CNS Diseases by Transcriptional Profiling

  2009cited by this paper
• A New Nerve Growth Factor-Mimetic Peptide Active on Neuropathic Pain in Rats

  2008cited by this paper
• Gambogic amide, a selective agonist for TrkA receptor that possesses robust neurotrophic activity, prevents neuronal cell death

  2007cited by this paper
• Pathways of survival induced by NGF and extracellular ATP after growth factor deprivation.

  2004cited by this paper
• Protective Effect of Nerve Growth Factor on Neurons after Traumatic Brain Injury

  2003cited by this paper
• Nerve growth factor induces anti‐apoptotic heme oxygenase‐1 in rat pheochromocytoma PC12 cells

  2003cited by this paper
• Neurotrophins and neurodegeneration

  2003cited by this paper
• Neurochemical findings in the MPTP model of Parkinson's disease

  2001cited by this paper
• Nerve growth factor prevents 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced cell death via the Akt pathway by suppressing caspase‐3‐like activity using PC12 cells: Relevance to therapeutical application for parkinson's disease

  2001cited by this paper
• Neurotrophic factors in Alzheimer's and Parkinson's disease brain.

  2000cited by this paper
• Oxidative Stress Induces a Form of Programmed Cell Death with Characteristics of Both Apoptosis and Necrosis in Neuronal Cells

  1998cited by this paper
• Anatomical methods in cell death.

  1995cited by this paper
• Synaptogenesis in hippocampal cultures: evidence indicating that axons and dendrites become competent to form synapses at different stages of neuronal development

  1994cited by this paper
• Nerve growth factor effects on pyridine nucleotides after oxidant injury of rat pheochromocytoma cells.

  1992cited by this paper
• Some Correlations between the Appearance of Human Fetal Reflexes and the Development of the Nervous Systemast

  1964cited by this paper

• Involvement of neurotrophins in the pathogenesis of Parkinson's disease

  2026cites this paper
• GK-2 — dipeptide mimetic of 4th loop NGF increases the level of BDNF and is active in the cell model of Parkinson's disease

  2025cites this paper
• 1953-2023. Seventy Years of the Nerve Growth Factor: A Potential Novel Treatment in Neurological Diseases?

  2024cites this paper
• A study on the mnemotropic and antidepressant-like effects of the low-molecular-weight mimetic of nerve growth factor, dipeptide GK-2, in experimental ischemic stroke

  2024cites this paper
• The Influence of the Low-Molecular-Weight NGF Mimetic Dipeptide GK-2 on the Behavior of Mice from Two Outbred Strains That Differ in Brain Weight

  2024cites this paper
• Peptides derived from growth factors: Exploring their diverse impact from antimicrobial properties to neuroprotection.

  2024cites this paper
• Pharmacokinetics of dimeric dipeptide mimetic of nerve growth factor GK-2 in rats. Part 2. Kinetics of distribution in organs and tissues

  2024cites this paper
• Growth factors and their peptide mimetics for treatment of traumatic brain injury.

  2023cites this paper
• Pharmacokinetics of dimeric dipeptide mimetic of nerve growth factor GC-2 in rats. Part 1. Single and multiple intravascular and extravascular administration. Testing the hypothesis of linearity of pharmacokinetics

  2023cites this paper
• Low molecular weight NGF mimetic GK‐2 normalizes the parameters of glucose and lipid metabolism and exhibits a hepatoprotective effect on a prediabetes model in obese Wistar rats

  2022cites this paper
• Low-Molecular-Weight Perorally Active Nerve Growth Factor Mimetic Reduces Manifestations of Diabetic Neuropathy in Wistar Rats

  2022cites this paper
• Dose-Dependent Effect of Nerve Growth Factor Mimetic GK-2 in a Wistar Rat Diabetes Model

  2021cites this paper
• Peptides Derived from Growth Factors to Treat Alzheimer’s Disease

  2021influential citation
• Low‐molecular mimetics of nerve growth factor and brain‐derived neurotrophic factor: Design and pharmacological properties

  2020cites this paper
• GK-2 Reduces Death of Cultured Granule Neurons in Cerebellum Induced by the Toxic Effects of Zinc Ions

  2020cites this paper
• Gac (Momordica cochinchinensis Spreng) fruit: A functional food and medicinal resource

  2019cites this paper
• A Novel Dipeptide NGF Mimetic GK-2 Selectively Activating the PI3K/AKT Signaling Pathway Promotes the Survival of Pancreatic β-Cells in a Rat Model of Diabetes

  2019cites this paper
• A Nerve Growth Factor Dipeptide Mimetic Stimulates Neurogenesis and Synaptogenesis in the Hippocampus and Striatum of Adult Rats with Focal Cerebral Ischemia

  2019cites this paper
• In Silico Investigation of the Binding of MCoTI-II Plant Defense Knottin to the γ-NGFserine Protease of the 7S Nerve Growth Factor Complex and Biological Activity of Its NGF Mimetic Properties.

  2019cites this paper
• Innovative Therapy for Alzheimer’s Disease-With Focus on Biodelivery of NGF

  2019cites this paper
• Bioactivity-Guided Isolation of Neuritogenic Factor from the Seeds of the Gac Plant (Momordica cochinchinensis)

  2018cites this paper
• Novel Technologies for Dipeptide Drugs Design and their Implantation

  2018cites this paper
• Antiangiogenic Effects of Nerve Growth Factor Loop 4 Monomeric Dipeptide Mimetic

  2017cites this paper
• Comparison of the Pharmacological Effects of Dimeric Dipeptide Nerve Growth Factor Mimetic GK-2 and Mexidol on the Model of Ischemic Stroke in Rats

  2017cites this paper
• Antiangiogenic Effects of Nerve Growth Factor Loop 4 Monomeric Dipeptide Mimetic

  2017influential citation
• Role of nerve growth factor in plasticity of forebrain cholinergic neurons

  2017cites this paper
• [The development of a pharmacologically active low-molecular mimetic of the nerve growth factor].

  2015cites this paper
• Behavioral effect of dipeptide NGF mimetic GK-2 in an in vivo model of rat traumatic brain injury and its neuroprotective and regenerative properties in vitro

  2015cites this paper
• Dimeric dipeptide mimetics of the nerve growth factor Loop 4 and Loop 1 activate TRKA with different patterns of intracellular signal transduction

  2015cites this paper
• Neurotrophic Effects of Mu Bie Zi (Momordica cochinchinensis) Seed Elucidated by High-Throughput Screening of Natural Products for NGF Mimetic Effects in PC-12 Cells

  2015cites this paper
• [The development of a pharmacologically active low-molecular mimetic of the nerve growth factor].

  2015cites this paper
• Theoretical grounds and technologies for dipeptide drug development

  2015cites this paper
• A Novel Dimeric Dipeptide Mimetic of the Nerve Growth Factor Exhibits Pharmacological Effects upon Systemic Administration and Has No Side Effects Accompanying the Neurotrophin Treatment

  2014cites this paper
• Original Nerve Growth Factor Mimetic Dipeptide GK-2 Restores Impaired Cognitive Functions in Rat Models of Alzheimer’s Disease

  2013cites this paper
• Original Nerve Growth Factor Mimetic Dipeptide GK-2 Limits the Manifestations of Hemorrhagic Stroke in Rats

  2013cites this paper